aphakia, postcataract
Showing 1 - 1 of 1
Aphakia, Postcataract Trial in Palo Alto (Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with
Recruiting
- Aphakia, Postcataract
- Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50.
-
Palo Alto, CaliforniaPalo Alto Medical Foundation
Apr 20, 2023